Clinical Study

Impact of Intravenous Fluid Challenge Infusion Time on Macrocirculation and Endothelial Glycocalyx in Surgical and Critically Ill Patients

Table 2

Perfused boundary region values.

VariablegrouptimepointGroup FastGroup Slowp valueNon-RESPONDERRESPONDERp value
(n=32)(n=34)(n=27)(n=39)

Perfused boundary regionallT01.801.72 to 2.051.891.76 to 2.080.1761.891.78 to 2.041.861.76 to 2.100.667
T11.911.75 to 2.131.961.85 to 2.260.2561.891.78 to 2.102.101.86 to 2.280.043
T601.891.77 to 2.082.021.72 to 2.160.5761.881.74 to 2.132.041.79 to 2.240.146
p value0.0950.2240.5210.014
ORT01.771.70 to 1.941.861.76 to 2.040.1181.851.73 to 1.951.761.73 to 2.020.336
T11.901.77 to 2.081.961.79 to 2.270.1711.881.78 to 2.121.961.79 to 2.260.286
T201.881.71 to 2.092.041.72 to 2.210.1651.981.72 to 2.151.991.73 to 2.140.985
T401.991.74 to 2.171.891.62 to 2.050.2631.941.74 to 2.151.871.64 to 2.040.346
T601.811.74 to 2.001.881.71 to 2.160.5841.831.70 to 1.991.901.72 to 2.120.404
p value0.0930.0340.0780.154
SEPT02.121.96 to 2.302.021.89 to 2.220.5601.971.75 to 2.161.961.85 to 2.180.857
T12.101.78 to 2.311.961.90 to 2.080.4271.991.78 to 2.072.282.04 to 2.520.027
T602.011.91 to 2.252.151.84 to 2.170.7912.071.85 to 2.172.192.05 to 2.330.115
T1201.871.77 to 2.222.011.91 to 2.290.4181.911.79 to 2.012.052.03 to 2.470.056
p value0.2120.8670.3760.290

Values are displayed as median (interquartile range). Significant difference towards baseline (Friedman test), intergroup significant difference marked in bold letters. Abbreviations: Group Fast: fast administration; Group Slow: slow administration; OR: operative cohort; SEP: patients with sepsis/septic shock.